Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.

Abstract:

:Persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). One of the characteristics of HCV infection is the unusual augmentation of oxidative stress, which is exacerbated by iron accumulation in the liver, as observed frequently in hepatitis C patients. Using a transgenic mouse model, in which HCC develops late in life after the preneoplastic steatosis stage, the core protein of HCV was shown to induce the overproduction of reactive oxygen species (ROS) in the liver. In excessive generation of ROS, HCV affects the steady-state levels of a mitochondrial protein chaperone, i.e. prohibitin, leading to an impaired function of the mitochondrial respiratory chain with the overproduction of ROS. Insulin resistance and hepatic steatosis, which frequently accompany HCV infection, exacerbate ROS production. On the other hand, HCV compromises some of the antioxidant systems, including heme oxygenase-1 and NADH dehydrogenase quinone 1, resulting in the provocation of oxidative stress, together with ROS overproduction, in the liver with HCV infection. Thus, HCV infection not only induces ROS but also hampers the antioxidant system in the liver, thereby exacerbating oxidative stress that would facilitate hepatocarcinogenesis. Combination with the other activated pathway, including an alteration in the intracellular signaling cascade of MAP kinase, along with HCV-associated disturbances in lipid and glucose metabolism would lead to the unusual mode of hepatocarcinogenesis, i.e. very frequent and multicentric development of HCC, in persistent HCV infection.

journal_name

Oncology

journal_title

Oncology

authors

Fujinaga H,Tsutsumi T,Yotsuyanagi H,Moriya K,Koike K

doi

10.1159/000333253

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

11-7

eissn

0030-2414

issn

1423-0232

pii

000333253

journal_volume

81 Suppl 1

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.

    abstract:OBJECTIVE:ETS-1 has been identified as a proto-oncogene and a transcription factor for tumor angiogenesis, which is essential for the growth, invasion and metastasis of solid tumors. The aim is to investigate the clinical implications of ETS-1 expression in peritoneal metastatic lesions of ovarian cancers. METHODS:In ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000079491

    authors: Fujimoto J,Aoki I,Toyoki H,Khatun S,Sato E,Sakaguchi H,Tamaya T

    更新日期:2004-01-01 00:00:00

  • Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

    abstract:BACKGROUND:We retrospectively investigated the treatment outcomes of second-line treatment with pazopanib or gemcitabine/docetaxel in patients with advanced soft tissue sarcoma (STS). METHODS:Ninety-one patients who were treated with pazopanib or gemcitabine/docetaxel for advanced STS between 1995 and 2015 were analyz...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492597

    authors: Kim JH,Park HS,Heo SJ,Kim SK,Han JW,Shin KH,Kim SH,Hur H,Kim KS,Choi YD,Kim S,Lee YH,Suh JS,Ahn JB,Chung HC,Noh SH,Rha SY,Kim HS

    更新日期:2019-01-01 00:00:00

  • In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.

    abstract::Retinoids are differentiating agents that have been used successfully for the treatment of acute promyelocytic leukemia. When combined with interferons, they are active in preventing second malignancies in patients with head and neck cancer. Our previous studies have demonstrated cytostatic effects of alltrans-retinoi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227583

    authors: Jiang SY,Shyu RY,Chen HY,Lee MM,Wu KL,Yeh MY

    更新日期:1996-07-01 00:00:00

  • Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.

    abstract:BACKGROUND:Over the last few years only one large randomized phase III study has tried to prospectively assess the safety of cetuximab and panitumumab in a head-to-head comparison. Despite the similar overall toxicity profile, cetuximab and panitumumab retain peculiar safety characteristics that deserve to be deeply in...

    journal_title:Oncology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1159/000486338

    authors: Petrelli F,Ardito R,Ghidini A,Zaniboni A,Ghidini M,Barni S,Tomasello G

    更新日期:2018-01-01 00:00:00

  • Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.

    abstract:OBJECTIVE:To report the outcomes of surgical resection of borderline resectable (BL) and locally advanced (LA) 'unresectable' pancreatic cancer after neoadjuvant chemotherapy. METHODS:A review of a prospectively maintained database for pancreatic resections was undertaken to identify patients undergoing resection for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000371745

    authors: Addeo P,Rosso E,Fuchshuber P,Oussoultzoglou E,De Blasi V,Simone G,Belletier C,Dufour P,Bachellier P

    更新日期:2015-01-01 00:00:00

  • A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.

    abstract:OBJECTIVE:The purpose of this study was to establish a new formula predicting liver metastasis in patients with colorectal cancer (CRC). METHODS:Nine previously reported predictive markers for liver metastasis and/or prognosis (COX-2, dysadherin, E-cadherin, beta-catenin, Ki-67, p53, laminin5gamma2, matrilysin and MUC...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151667

    authors: Ochiai H,Nakanishi Y,Fukasawa Y,Sato Y,Yoshimura K,Moriya Y,Kanai Y,Watanabe M,Hasegawa H,Kitagawa Y,Kitajima M,Hirohashi S

    更新日期:2008-01-01 00:00:00

  • Mitomycin therapy in gastric cancer.

    abstract::Adenocarcinoma of the stomach remains a significant cause of mortality worldwide. The majority of patients present with stage III or IV disease, negating surgery as a curative option. Numerous drugs have been tested over the past 2 decades in single-agent and combination chemotherapy trials. Given by intravenous bolus...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1159/000227249

    authors: Schnall S,Macdonald JS

    更新日期:1993-04-01 00:00:00

  • Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer.

    abstract::In order to assess the feasibility of a sequential hormonal treatment after tamoxifen failure, 24 postmenopausal advanced breast cancer patients (median age 60 years; ECOG PS < or = 1) were treated with formestane (4-hydroxyandrostenedione) 250 mg i.m. fortnightly; 19 patients were estrogen receptor-positive. The site...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227510

    authors: Noberasco C,Bajetta E,Zilembo N,Di Leo A,Cappuzzo F,Bartoli C,Bono A,Bichisao E

    更新日期:1995-11-01 00:00:00

  • Diagnostic imaging of hepatocellular carcinoma: recent progress.

    abstract::The diagnostic imaging of hepatocellular carcinoma (HCC) has recently undergone marked progress. The advent of the ultrasound (US) contrast agent Sonazoid, approved in January 2007, and magnetic resonance imaging (MRI) with the liver-specific MRI contrast agent gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic ac...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000333265

    authors: Kudo M

    更新日期:2011-01-01 00:00:00

  • Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate Cancer.

    abstract:PURPOSE:Cancer-related fatigue is a common complaint during cancer treatment and is often associated with cognitive impairment. This study examined cognitive deficits that were associated with fatigue symptoms during external-beam radiation therapy (EBRT) in men with localized prostate cancer. METHODS:A total of 36 pa...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000487081

    authors: Feng LR,Espina A,Saligan LN

    更新日期:2018-01-01 00:00:00

  • Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

    abstract:BACKGROUND:The clinical features of hepatocellular carcinoma (HCC) differ in patients with and without cirrhosis. OBJECTIVE:We aimed to investigate the long-term outcomes of noncirrhotic HCC patients after curative resection. METHODS:We retrospectively examined 649 consecutive patients with HCC who underwent curative...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000477173

    authors: Lee HW,Choi GH,Kim DY,Park YN,Kim KS,Choi JS,Ahn SH,Han KH

    更新日期:2017-01-01 00:00:00

  • Is capecitabine efficacious in triple negative metastatic breast cancer?

    abstract:BACKGROUND:Recent data suggest that capecitabine may have little efficacy in women with metastatic triple negative breast cancer (TNT). We have therefore retrospectively analysed capecitabine outcome in the TN subgroup of patients with locally advanced or metastatic breast cancer treated in our unit. PATIENTS AND METH...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000323175

    authors: Kotsori AA,Dolly S,Sheri A,Parton M,Shaunak N,Ashley S,Walsh G,Johnston S,Smith IE

    更新日期:2010-01-01 00:00:00

  • Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

    abstract:OBJECTIVES:18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is useful for differentiating benign from malignant lesions, evaluating tumor stage, monitoring the response to therapy and detecting tumor recurrence in a variety of malignancies. Nevertheless, its use in patients with hepatocellular carcinoma (H...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000111715

    authors: Yoon KT,Kim JK,Kim DY,Ahn SH,Lee JD,Yun M,Rha SY,Chon CY,Han KH

    更新日期:2007-01-01 00:00:00

  • Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.

    abstract:OBJECTIVE:To evaluate the clinical and cost benefits of the administration of aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) during high-dose chemotherapy (HDCT). METHODS:We retrospectively reviewed the charts of patients who received HDCT at our institution between January 2009 and ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000479032

    authors: Nakamura A,Kojima Y,Miyazawa K,Matsumoto S,Iida H,Nagai H

    更新日期:2017-01-01 00:00:00

  • Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.

    abstract::Acute myeloid leukemia (AML) originates from self-renewing leukemic stem cells (LSCs), an ultimate therapeutic target in AML. Eradication of LSCs should be a critical and efficient therapeutic approach for the cure of AML. T-cell immunoglobulin mucin-3 (TIM-3) is expressed in most types of AML LSCs, but not in normal ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000431062

    authors: Kikushige Y,Miyamoto T

    更新日期:2015-01-01 00:00:00

  • A phase II study of carboplatin in nasopharyngeal carcinoma.

    abstract::This is a phase II study to evaluate the efficacy and toxicity of short-course carboplatin in advanced-stage nasopharyngeal carcinoma (NPC). Thirty-three previously untreated stage III-IV NPC patients were studied. Carboplatin was given as a rapid intravenous injection every 3 weeks. The dose of carboplatin was calcul...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227689

    authors: Chi KH,Chang YC,Chan WK,Liu JM,Law CK,Lo SS,Shu CH,Yen SH,Whang-Peng J,Chen KY

    更新日期:1997-05-01 00:00:00

  • Restricted activity of serum blocking factors related to a common tumour antigen in mice.

    abstract::Mice of four different inbred strains (CBA, Balb/c, C57Bl/6 and DBA/2), bearing different transplanted tumours (methylcholanthrene-induced sarcomas, B16 melanoma and P-815 mastocytoma), were tested for cellular immune reactivity to the synthetic encephalitogenic peptide of human myelin basic protein by the leucocyte a...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225732

    authors: Yong WK,Halliday WJ

    更新日期:1983-01-01 00:00:00

  • Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.

    abstract:OBJECTIVE:We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer QLQ-PR25 when applied to Korean prostate cancer (PC) patients. METHODS:A total of 172 patients who underwent curative radical prostatectomy (RP) with or without adjuvant androgen d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000355689

    authors: Park J,Shin DW,Yun SJ,Park SW,Jeon SS,Kwak C,Kwon TG,Kim HJ,Ahn H

    更新日期:2013-01-01 00:00:00

  • Effects of theophylline treatment on mouse B-16 melanoma cells in vitro.

    abstract::The effects of theophylline treatment on mouse B-16 melanoma cell growth, metabolism, and membrane antigen expression in vitro were studied. Theophylline treatment inhibited DNA synthesis and the cell growth rate, and caused an elevation of intracellular cAMP levels. Cells treated with theophylline became elongated an...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225467

    authors: Kolb CA,Mansfield JM

    更新日期:1980-01-01 00:00:00

  • Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.

    abstract::Twenty-two patients with metastatic breast carcinoma were treated with a combination of cisplatin (100 mg/m2 i.v. day 1) and etoposide (100 mg/m2 i.v. days 1-3). Eligible patients had measurable disease with normal organ functions, performance status < 3, age < 70 years and no previous chemotherapy for metastatic dise...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227364

    authors: Lluch A,Azagra P,Cervantes A,Muñoz M,Alberola V,Santabarbara P,García-Conde J

    更新日期:1994-07-01 00:00:00

  • Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients.

    abstract:OBJECTIVE:The pretreatment neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) have been reported to be useful as markers for prognostic factors and metastasis in several cancers. The aim of this study was to identify the predictor of lymph node (LN) metastasis by pretreatment NLR and PLR in...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000497184

    authors: Aoyama T,Takano M,Miyamoto M,Yoshikawa T,Kato K,Sakamoto T,Takasaki K,Matsuura H,Soyama H,Hirata J,Suzuki A,Sasa H,Tsuda H,Furuya K

    更新日期:2019-01-01 00:00:00

  • Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.

    abstract::Lonidamine alone or in combination with hyperthermic perfusion, with or without melphalan, was investigated in 12 patients with stage II, III, and IV malignant melanoma. The authors evaluated the most effective methods and sequence of Lonidamine administration. Preliminary results suggest that the highest effectivenes...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225899

    authors: Cavaliere R,Di Filippo F,Varanese A,Carlini S,Calabro A,Aloe L,Piarulli L

    更新日期:1984-01-01 00:00:00

  • Anal carcinoma: a clinical approach to p53 and RB gene proteins.

    abstract::The role of p53, retinoblastoma (RB) and c-erbB-2 gene proteins in the pathogenesis of anal carcinomas has been examined. A total of 97 patients were included in the study. c-erbB-2, RB and p53 proteins were abnormal in 0, 5 and 34% of the cases, respectively. No correlation was observed between p53 and age, sex, tumo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227590

    authors: Tanum G,Holm R

    更新日期:1996-09-01 00:00:00

  • 5-fluorouracil uptake by irradiation perturbed tumor.

    abstract::An in vitro system was used to study the uptake of 5-fluorouracil by LSA ascites tumor cells. Changes in drug uptake with cell age and following a 1,000-rad radiation perturbation of the cell population were studied. DNA synthesis and drug uptake were highest during early rapid tumor growth and decreased with tumor ag...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225540

    authors: Young JA,Maruyama Y

    更新日期:1981-01-01 00:00:00

  • Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.

    abstract::The expression of cyclin-dependent kinase 1 (cdc2), cyclin A and cyclin B1 was immunohistochemically studied in 101 hepatocellular carcinomas (HCC). cdc2 overexpression was directly related to advanced stage, portal invasion, intrahepatic metastasis, poor differentiation, high alpha-fetoprotein level, large size, high...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012140

    authors: Ito Y,Takeda T,Sakon M,Monden M,Tsujimoto M,Matsuura N

    更新日期:2000-06-01 00:00:00

  • Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.

    abstract:BACKGROUND:There has been no clinically useful diagnostic or prognostic biomarker for renal cell carcinoma (RCC). Serum γ-glutamyltransferase (GGT) activity has been reported to be a prognostic marker for several types of cancer including RCC. Exosomes or small extracellular vesicles present in body fluids have potenti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508688

    authors: Horie K,Kawakami K,Fujita Y,Matsuda Y,Arai T,Suzui N,Miyazaki T,Koie T,Mizutani K,Ito M

    更新日期:2020-01-01 00:00:00

  • Clinical experience with hyperthermia in conjunction with radiation therapy.

    abstract::The authors have reviewed the medical records of 421 sessions of hyperthermia treatments in 73 patients treated between 1987 and 1992 at the University Heights Cancer Center and the Indiana University Medical Center in Indianapolis, Ind. Temperatures attained during the course of therapy on each patient have been aver...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227209

    authors: Shidnia H,Hornback N,Ford G,Shen RN

    更新日期:1993-09-01 00:00:00

  • Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.

    abstract:PURPOSE:Patient nonadherence to oral antineoplastic therapy is a well-recognized barrier to effective treatment. In order to identify patients who may need additional support to become adherent, it is important to have a useful tool that takes into account all the parameters of adherence to prescription. The aim of thi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000342087

    authors: Thivat E,Van Praagh I,Belliere A,Mouret-Reynier MA,Kwiatkowski F,Durando X,Mahammedi H,Dillies AF,Chollet P,Chevrier R

    更新日期:2013-01-01 00:00:00

  • Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.

    abstract:OBJECTIVE:The purpose of this study was to investigate the longitudinal changes in quality of life (QoL) for patients with advanced stage (stage III or IV) head and neck squamous cell carcinoma (HNSCC) following primary radiotherapy (RT) or concomitant chemoradiotherapy. METHODS:From January 2001 to January 2003, 149 ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000086982

    authors: Fang FM,Tsai WL,Chien CY,Chiu HC,Wang CJ,Chen HC,Hsiung CY

    更新日期:2005-01-01 00:00:00

  • Acute disseminated intravascular coagulation syndrome in cancer patients.

    abstract::Hemostatic abnormalities are rather frequent in cancer patients either in hematological or in solid tumors. Acute disseminated intravascular coagulation (DIC) is a rare coagulopathy in cancer patients, but when it develops it becomes rapidly fatal. Between June 1988 and December 1992 we observed 8 cases of acute DIC o...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227520

    authors: Pasquini E,Gianni L,Aitini E,Nicolini M,Fattori PP,Cavazzini G,Desiderio F,Monti F,Forghieri ME,Ravaioli A

    更新日期:1995-11-01 00:00:00